Eurofins Scientific SE
ERFSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $12,940 | $9,656 | $10,034 | $11,296 |
| - Cash | $753 | $614 | $681 | $1,221 |
| + Debt | $4,114 | $3,610 | $3,544 | $3,927 |
| Enterprise Value | $16,301 | $12,652 | $12,896 | $14,001 |
| Revenue | $3,612 | $3,532 | $3,419 | $3,305 |
| % Growth | 2.3% | 3.3% | 3.4% | – |
| Gross Profit | $810 | $3,956 | $757 | $1,108 |
| % Margin | 22.4% | 112% | 22.1% | 33.5% |
| EBITDA | $818 | $614 | $753 | $554 |
| % Margin | 22.6% | 17.4% | 22% | 16.8% |
| Net Income | $247 | $186 | $221 | $159 |
| % Margin | 6.8% | 5.3% | 6.5% | 4.8% |
| EPS Diluted | 1.16 | 0.83 | 1 | 0.67 |
| % Growth | 39.8% | -17% | 49.3% | – |
| Operating Cash Flow | $526 | $789 | $530 | $627 |
| Capital Expenditures | -$221 | -$311 | -$218 | -$287 |
| Free Cash Flow | $305 | $478 | $313 | $340 |